Press release

Guerbet provides 100 academic scholarships for students
Artificial Intelligence in Medicine Review Course through ABAIM
allows students to obtain their educational certification

Princeton, NJ – November 9, 2021 – Guerbet LLC, the US affiliate of Guerbet, a global
leader in medical imaging, announced today that they will be providing 100 academic
educational scholarships to the American Board of Artificial Intelligence in Medicine(ABAIM) to fund participation in their AI in Medicine Review Course.
Guerbet dedicates 10% of its annual revenue to continual innovation, expanding
education as well as research and development surrounding artificial intelligence in themedical field. As a founding sponsor of ABAIM, Guerbet’s recent sponsorship will beutilized to develop scholarships and offer tuition free access to the course for 100
students. ABAIM targets data scientists, nurses and clinicians, as well as high school
and college students interested in advancing the newly-developed field of artificial
intelligence and its applications in all fields of medicine.
“We are proud to be the founding sponsor of the American Board of Artificial Intelligencein Medicine,” said Tom McLaughlin, Vice President North American at Guerbet. “We feelstrongly that technology in health care improves patient outcomes and provides medical
professionals with additional tools and resources to further advance medicine in theirrespective fields. ABAIM’s course is an excellent opportunity for students and clinicians
to gain a functional knowledge of AI and its healthcare applications.”
Guerbet and ABAIM believe technology and artificial intelligence will enhance thecapabilities of medical professionals and allow for more time to be focused on patientinteraction and care. The AI in Medicine Review Course is a comprehensive, two-day
course designed by a team of clinician-data scientists with an AI focus. The aim of thereview course is to empower and educate students, clinicians and industry executives intheir pursuit of integrating artificial intelligence into medicine.
“We have found a fantastic partner in Guerbet,” said Dr. Orest Boyko, ABAIM Co-Chair.
“They bring a great deal of additional knowledge and expertise on AI in the Medicalfield.” ABAIM Chair Dr. Anthony Chang added, “Their sponsorship has allowed us toprovide tuition-free access to our review course for hundreds of students and medicalprofessionals and to imbue a new generation with the knowledge required to build an AIenabled healthcare system. We are excited to see this partnership grow.”

1

Press release
In addition to the review course, the ABAIM also offers an educational certification tostudents and healthcare professionals who meet the standards of competency inmedical AI. In the future, the ABAIM plans to also offer board certification. Both thereview course and certification process are open to all stakeholders, including students.
The ABAIM, in partnership with Guerbet, is eager to develop the next generation ofmedical professionals by engaging with high school and college students, as well ascurrent healthcare professionals. By empowering the healthcare community with agreater understanding of AI technology, ABAIM and Guerbet hope to better harness themassive potential of AI, leading to a more effective healthcare system and better
outcomes for patients everywhere.

About Guerbet
At Guerbet, we build lasting relationships so that we enable people to live better. This is ourpurpose. We are a leader in medical imaging worldwide, offering a wide range of pharmaceuticalproducts, medical devices, digital and AI solutions for diagnostic and interventional imaging. Apioneer since 95 years in the field of contrast media with over 2,600 people globally, we arecontinuously innovating with 10% of revenue dedicated to Research & Development and four
centers in France, Israel, and the United States. Guerbet (GBT) is listed on Euronext Paris(segment B – mid-caps) and generated €712 million in revenue in 2020.
For more information, please visit www.guerbet-us.com.
About ABAIMThe American Board of Artificial Intelligence in Medicine (ABAIM) is a nonprofit multidisciplinary
advisory group of domain experts formed to provide educational content and certification
examinations for Artificial Intelligence in Medicine. The ABAIM Review Course is acomprehensive, two-day course on basic concepts in artificial intelligence in clinical medicine andhealthcare designed by a team of clinician-data scientists as well as clinicians with an AI focus
and data scientists who are involved in healthcare.
Learn more at abaim.org
Media relations
Kelly Starkey + 435.901.3278 + kelly@starkeyconsulting.com

2